Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Sporos Bioventures

Founders Alex Cranberg Dana Levy Joseph Kekst Louis Feinberg Peter Feinberg

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 4
Rounds per year 5.00
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Biopharma
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sporos Bioventures:
Typical Co-investors
Sporos Bioventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sporos Bioventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
China Post Beijing, Beijing, China
Fangde Zhilian Investment China, Guangdong, Shenzhen
Fomou Assets -
Glass Capital Management New Jersey, Saddle River, United States
Golzern Holding GmbH -
Haodao Capital -
Investissement Desjardins Canada, Montréal, Quebec
Latin Idea Ventures Distrito Federal, Mexico, Mexico City
Latour Capital France, Ile-de-France, Paris
Leeh Capital China, Hangzhou, Zhejiang
Leonis Investissement -
Pocket University China, Jiangsu, Suzhou
RSM Investments -
Spiegel Capital Management California, San Diego, United States
Tianjin Woda Guquan Touzi -
Tomato Bank Japan, Okayama, Okayama Prefecture
Yara ventures -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tvardi Therapeutics

Biotechnology
Health Care
Pharmaceutical
$72M15 Jun 2021 Houston, Texas, United States

Stellanova Therapeutics

Biotechnology
$15M03 Jun 2021 Houston, Texas, United States

Asylia Therapeutics

Biotechnology
Health Care
Therapeutics
$14M25 May 2021 Houston, Texas, United States

Nirogy Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$16M26 Jan 2021 Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sporos Bioventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 38M
Rounds per year 5.00
Peak activity year 2021
Lead investments 0
Follow on index 0.20
Group Appearance index 0.60

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Tvardi Therapeutics

Biotechnology
Health Care
Pharmaceutical
$72M15 Jun 2021 Houston, Texas, United States

Stellanova Therapeutics

Biotechnology
$15M03 Jun 2021 Houston, Texas, United States

Asylia Therapeutics

Biotechnology
Health Care
Therapeutics
$14M25 May 2021 Houston, Texas, United States

Nirogy Therapeutics

Biopharma
Biotechnology
Pharmaceutical
$16M26 Jan 2021 Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: